Skip to content

Application of hyaluronic acid in the treatment of periodontitis (gum disease)

Clinical and radiographic evaluation of intrabony periodontal defects treated with hyaluronic acid or enamel matrix proteins. A 6-month prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN22392064
Enrollment
40
Registered
2024-03-12
Start date
2019-06-01
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical treatment of intrabony vertical defects in patients with Periodontitis stage III, grades A and B Oral Health

Interventions

A randomized prospective 6-month, single-blind clinical, single-center, interventional study with a 1:1 allocation ratio according to computer-generated tables composed of two groups (test group: ope

Sponsors

University of Medicine and Farmacy "Victor Babes" Timisoara
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. No systemic diseases that could in?uence the outcome of the therapy 2. Presence of 2-3 walls IBD = 3 mm 3. An interproximal PD = 6 mm 4. 6 weeks after subgingival instrumentation at the experimental sites 5. Good oral hygiene 6. Non-smokers

Exclusion criteria

Exclusion criteria: 1. Patients with systemic diseases known to affect the outcome of periodontal therapy 2. Immunocompromised individuals 3. Pregnant or lactating females 4. Tobacco smokers or tobacco use in any form 5. Non-compliant patients 6. Prolonged antibiotic treatment or anti-inflammatory treatment within 6 months prior the surgery 7. Grade C periodontitis 8. Furcation involvement at the same tooth 9. Mobility grade II/III 10. Poor oral hygiene 11. Patients with parafunctional habits 12. Patients who had periodontal surgery in the last 6 months 13. Orthodontic treatment during the previous year 14. Occlusion trauma 15. Interproximal open contact points 16. One-walled or combined one- and two-walled defects confirmed upon surgical exposure

Design outcomes

Primary

MeasureTime frame
Clinical attachment level (CAL) will be measured using periodontal probe at baseline and 6 months after the procedure

Secondary

MeasureTime frame
1. Probing Depth (PD) - measured using a periodontal probe at baseline and 6-month follow-up 2. Gingival Margin Level (GML) - measured using a periodontal probe at baseline and 6-month follow-up 3. Bleeding on Probing (BOP) - measured using a periodontal probe at baseline and 6-month follow-up 4. Full Mouth Bleeding Score (FMBS) - measured using a periodontal probe at baseline and 6-month follow-up 5. Full Mouth Plaque Score (FMPS) - measured using a periodontal probe at baseline and 6-month follow-up 6. Defect Depth (BC-BD) - measured on radiographs using radiographic imaging software at baseline and 6-month follow-up. 7. Defect Width (DW) - measured on radiographs using radiographic imaging software at baseline and 6-month follow-up. 8. Early Healing Index (EHI) - analyzed clinically 1 week after surgery

Countries

Romania

Contacts

Public ContactOctavia-Carolina Vela
vela.octavia@umft.ro+40741706965

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 21, 2026